DG vs LCTX · P/E 15, rev $22.08B vs rev $2.8M
Dollar General Corporation (DG) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported DG revenue for 2026-07-31 was $22.08B. Net income was $994.4M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
DG currently screens at market cap $22.87B and trailing P/E 14.7. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the DG and LCTX stock pages for the full models.
Not investment advice.